Expression of p53, p21 /waf l, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas

Similar documents
lymphoma. Comparative study with the wild type

MOLECULAR BASIS OF ONCOGENESIS

Oncolytic virus strategy

CELL CYCLE MOLECULAR BASIS OF ONCOGENESIS

Oncogenes and tumour suppressor genes

Regulation of cell cycle. Dr. SARRAY Sameh, Ph.D

HAEMATOLOGICAL MALIGNANCY

EBV infection B cells and lymphomagenesis. Sridhar Chaganti

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney

Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis

, , 2011 HODGKIN LYMPHOMA

Determination Differentiation. determinated precursor specialized cell

Early Embryonic Development

Molecular biology :- Cancer genetics lecture 11

Multistep nature of cancer development. Cancer genes

Immunopathology of Lymphoma

Cancer genetics

Disorders of Cell Growth & Neoplasia. Lecture 4 Molecular basis of cancer

Immunohistochemical Expressions of AKT, ATM and Cyclin E in Oral Squamous Cell Carcinoma

Cell Cycle and Cancer

A class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.

Introduction to Cancer Biology

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Deregulation of signal transduction and cell cycle in Cancer

Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α

p53 and Apoptosis: Master Guardian and Executioner Part 2

Cell cycle and Apoptosis. Chalermchai Mitrpant

Cell Cycle Checkpoint Genes and Cancer

MicroRNA dysregulation in cancer. Systems Plant Microbiology Hyun-Hee Lee

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II

Prof. R. V. Skibbens

Cancer Biology How a cell responds to DNA Damage

Identification and characterization of genes responsive to apoptosis: Application of DNA chip technology and mrna differential display

Prof. R. V. Skibbens. Cell Cycle, Cell Division and Cancer (Part 2)

Nodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Genome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer

Control of Cell Cycle. Unit 2 Part f III

Determination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection

Tumour growth environment modulates Chk1 signalling pathways and sensitivity to Chk1 inhibition

Role of cyclin E and p53 expression in progression of early gastric cancer

Chapt 15: Molecular Genetics of Cell Cycle and Cancer

Hodgkin Lymphoma Causes, Risk Factors, and Prevention

SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD)

XIII. Molecular pathogenesis of transformed lymphomas

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

CINtec PLUS Cytology. Interpretation training

Apoptosis Oncogenes. Srbová Martina

VIRUSES AND CANCER Michael Lea

Study of expression of P53 in Gastric Carcinoma As a prognostic indicator

Abnormality of p16/p38mapk/p53/wipl pathway in papillary thyroid cancer

Lymphoma Case Scenario 1

TARGETS OF CYCLIN D1-CDK

Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR

Regarding techniques of proteomics, there is:

Lecture 10. G1/S Regulation and Cell Cycle Checkpoints. G1/S regulation and growth control G2 repair checkpoint Spindle assembly or mitotic checkpoint

BIT 120. Copy of Cancer/HIV Lecture

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Negative growth regulators of the cell cycle machinery and cancer

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:

Emerging" hallmarks of cancer, a. Reprogramming of energy metabolism b. Evasion of the immune system, Enabling characteristics, a.

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Cancer and Gene Alterations - 1

Chapter 9, Part 1: Biology of Cancer and Tumor Spread

Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center

TUMOR-SUPPRESSOR GENES. Molecular Oncology Michael Lea

3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships

Follicular Lymphoma. ced3 APOPTOSIS. *In the nematode Caenorhabditis elegans 131 of the organism's 1031 cells die during development.

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin. Lymphomas and Post-transplant Lymphoproliferative Disorders:

Cancer: Brief Introduction. First stage: Mutations in genes progressively accumulate so that there is unrestrained cell proliferation

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

The prognostic role of p-53 protein Immunohistochemical expression in multiple myeloma

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

oncogenes-and- tumour-suppressor-genes)

7.012 Problem Set 6 Solutions

Prof. R. V. Skibbens

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

Regulators of Cell Cycle Progression

Supplementary Figure 1: Expression of NFAT proteins in Nfat2-deleted B cells (a+b) Protein expression of NFAT2 (a) and NFAT1 (b) in isolated splenic

Invited Re vie W. Molecular genetics of ovarian carcinomas. Histology and Histo pathology

NEW IHC A n t i b o d i e s

3/23/2017. Disclosure of Relevant Financial Relationships. Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?!

MECHANISMS OF B-CELL LYMPHOMA PATHOGENESIS

Methotrexate-associated Lymphoproliferative Disorders

An Overview. Paediatric Oncology. In Malawi

BIOMEDICAL SCIENCES GRADUATE PROGRAM SPRING 2018

CELL BIOLOGY - CLUTCH CH CANCER.

Incidence. Bimodal age incidence 15-40, >55 years Childhood form (0-14) more common in developing countries M:F=1.5:1; in all subtypes except NS

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

Oncogenes and Tumor. supressors

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.

Transcription:

Histol Histopathol (2000) 15: 445-453 http://www.ehu.es/histol-histopathol Histology and Histopathology Cellular and Molecular Biology Expression of p53, p21 /waf l, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas P. Kanavaros l, K. Stefanaki 2, J. Vlachonikolis 3, G. Eliopoulos 4, S. Kakolyriss, D. Rontogiannis, V. Gorgoulis 7 and V. Georgoulias5 'Department of Histology, University of Thessalia, Departments of *Pathology, abiostatistics, 4Hematology, 50ncology, University of Crete, G~epartment of Pathology, Evagelismos Hospital of Athens, 'Department of Histology, University of Athens, Athens, Greece Summary. The aim was to investigate the combined immunoexpression of p53, p21, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas (HL) and correlate expression patterns with the histotype and the Epstein- Barr Virus (EBV) status. Paraffin-sections from 56 cases of HL (18 nodular sclerosis and 38 mixed cellularity) and from ten "reactive" lymph nodes were investigated. P53, p21, bcl-2, bax, Rb and Ki67 proteins were detected in Hodgkin and Reed-Sternberg (HRS) cells in 35156,56156,24156, 23156,56156 and 56/56 cases of HL, respectively. No correlation was found between the expression of each protein and the EBV status or the histotype of HL. Comparison between p53 and p21 staining revealed two patterns: a) p53+/p21+ (35 cases); and b) p53-/p21+ (21 cases). The pattern p53+/p21+ suggests wild type p53 protein able to induce the expression of p21 while the p53-/p21+ pattern suggests p53-independent p21 expression. These results are consistent with the interpretation that inactivating p53 gene mutations may be rare in HL. Comparison between bcl-2 and bax staining showed a statistically significant relationship (p<0.001) for coexpression (19 cases) or absence of expression of both proteins (28 cases) in HRS cells. In contrast, bax expression was observed in most lymphoid cells in all "reactive" lymph nodes. Since the proapoptotic bax protein may act as tumour suppressor it is possible that the absence of this,protein in HRS cells in a substantial proportion of HL may confer growth advantage and play a role in their pathogenesis. This could suggest bax gene alterations in some HL since in other studies acute lymphoblastic leukaemia cell lines demonstrate bax gene mutations with loss of bax immunoexpression. Another possibility is that reduced bax expression may be due to post transcriptional regulation, as was described in lymphoma cell lines. Comparison between Rb and Ki67 staining disclosed two main deviations from the normal parallel relationship in reactive lymph nodes: a) 2 cases with low Offprint requests to: Prof. V. Georgoulias, Deparrnent of Oncology, University Hospital of Heraklion. 71 100 Heraklion, Crete. Hellas, Greece. Fax: 0030 811392802 Rb and high Ki67 expression possibly reflecting loss of Rb expression due to chromosome loss or to other abnormalities in the structure or the expression of Rb gene; and b) 9 cases with high RB and low Ki67 possible reflecting an attempt of Rb protein in excess to induce cell cycle arrest. Taken together, our findings provide combined immunohistological evidence for deregulated expression of cell-cycle and apoptosis-related proteins, that may play a role in the pathogenesis of HL. Key words: Hodgkin's lymphomas, Immunohistochemistry, Apoptosis, Cell 'cycle Introduction Despite the enormous variations in human tumour types a common theme in oncogenesis is the perturbation of the complex network proliferationlcellcycle arrest/differentiation/apoptosis. Analysis of the proteins involved in this network should help to clarify the multiple pathways of oncogenesis. p53 has a central role in the regulation of the cell-cycle and the apoptosis (Miyashita and Reed, 1994; Cox, 1997; Morente et al., 1997; Evan and Littlewood, 1998; Prives and Hall, 1999). There is evidence that the levels of p53 a) are regulated by its interaction with mdm2, b) are modified after cellular stress and c) are altered by a stress signal independent pathway in which the product of the alternative reading frame (ARF) of the P16 locus is induced and this leads to abrogation of mdm2-targeted destabilization of p53 (Prives and Hall, 1999). Wild-type (wt) p53 transcriptionally upregulates p2llwafl protein which inactivates the cyclin/cyclin-dependent-kinase (CDK) complexes resulting in inhibition of Retinoblastoma (Rb) protein phosphorylation and blocking the cell-cycle progression in the G1-S transition (El Deiry et al., 1993; Cordon-Cardo and Richon, 1994; Waga et al., 1994; Elledge, 1996, Cox, 1997; Prives and Hall, 1999). In addition, p2llwafl protein blocks the action of proliferating cell nuclear antigen (PCNA), impeding DNA replication (Waga et